Drug touted by Trump as COVID-19 treatment tied to increased risk of death: study

US

FILE PHOTO: A nurse shows a Hydroxychloroquine pill, amid the coronavirus disease (COVID-19) outbreak, at Nossa Senhora da Conceicao hospital in Porto Alegre, Brazil, April 23, 2020. REUTERS/Diego Vara

(Reuters) – Malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking, was tied to increased risk of death in a study in 96,000 COVID-19 patients, according to a paper published in the Lancet.

The study found here that people treated with hydroxychloroquine, or the closely related drug chloroquine, had higher risk of in-hospital death when compared to those who had not been given the drug.

Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty

Products You May Like

Articles You May Like

Cambodian conservationists hopeful for revival of rare royal turtle
U.S. workplace safety agency steps up COVID-19 inspections
U.S. Senator Rubio: Consensus seen to give companies more time for PPP loans
Film star and Trump accuser Stormy Daniels returns as comic book hero
Harley plans to ship fewer models to U.S. dealers: WSJ

Leave a Reply

Your email address will not be published. Required fields are marked *